FDA Approved: AQVESME — Original Application (Agios Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved AQVESME (mitapivat) from Agios Pharmaceuticals as the original application for the treatment of pyruvate kinase deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyruvate Kinase Deficiency

Drugs mentioned

• AQVESME (mitapivat)

Snippet

ORIG AP for AQVESME (MITAPIVAT)